 |
|
|
|
FMC409a
Frozen multiple organ cancer tissue array, 20 cases/40 cores, replacing FMC409
|
|
| Microarray Panel: | Frozen multiple organ carcinoma tissue microarray, containing 5 cases of breast invasive ductal carcinoma, 7 ovarian adenocarcinoma, 1 soft tissue giant cell tumor, 2 skin squamous cell carcinoma, 2 oral cavity mullerian mixed tumor, 1 each of lung squamous cell carcinoma and small cell carcinoma and 1 testis seminoma, duplicated cores per case |
| Cores: | 40 |
|
| Cases: | 20 |
| Layout: | 8 cols × 5 rows |
| Core Diameter: | 2 mm |
| Thickness: | 5 µm | | Quality Control: | Anti-Actin confirmed | | Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
| Notes: | Tissues were snap frozen in liquid nitrogen immediately after excision and were embedded in OCT. The array sections are 5-8 µm in thickness, mounted on positively charged glass slides, and briefly fixed by cold acetone. |
*Tissue Microarray Slide Types:
- Unstained: unstained
frozen
tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Microarray Panel Display | Legend: | Bre - Breast,
Lun - Lung,
Ora - Oral cavity,
Ova - Ovary,
Ski - Skin,
Sof - Soft tissue,
Tes - Testis
 - Malignant tumor
|
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Type † |
|
A1 |
1 |
F |
43 |
Breast |
Invasive ductal carcinoma |
Malignant |
|
A2 |
2 |
F |
43 |
Breast |
Invasive ductal carcinoma |
Malignant |
|
A3 |
3 |
F |
52 |
Breast |
Invasive ductal carcinoma |
Malignant |
|
A4 |
4 |
F |
52 |
Breast |
Invasive ductal carcinoma |
Malignant |
|
A5 |
5 |
F |
33 |
Breast |
Invasive ductal carcinoma |
Malignant |
|
A6 |
6 |
F |
33 |
Breast |
Invasive ductal carcinoma |
Malignant |
|
A7 |
7 |
F |
48 |
Breast |
Invasive ductal carcinoma |
Malignant |
|
A8 |
8 |
F |
48 |
Breast |
Invasive ductal carcinoma |
Malignant |
|
B1 |
9 |
F |
39 |
Breast |
Invasive ductal carcinoma |
Malignant |
|
B2 |
10 |
F |
39 |
Breast |
Invasive ductal carcinoma |
Malignant |
|
B3 |
11 |
F |
55 |
Ovary |
Adenocarcinoma |
Malignant |
|
B4 |
12 |
F |
55 |
Ovary |
Adenocarcinoma |
Malignant |
|
B5 |
13 |
F |
50 |
Ovary |
Adenocarcinoma |
Malignant |
|
B6 |
14 |
F |
50 |
Ovary |
Adenocarcinoma |
Malignant |
|
B7 |
15 |
F |
51 |
Ovary |
Adenocarcinoma |
Malignant |
|
B8 |
16 |
F |
51 |
Ovary |
Adenocarcinoma |
Malignant |
|
C1 |
17 |
F |
49 |
Ovary |
Adenocarcinoma |
Malignant |
|
C2 |
18 |
F |
49 |
Ovary |
Adenocarcinoma |
Malignant |
|
C3 |
19 |
F |
61 |
Ovary |
Adenocarcinoma |
Malignant |
|
C4 |
20 |
F |
61 |
Ovary |
Adenocarcinoma |
Malignant |
|
C5 |
21 |
F |
55 |
Ovary |
Adenocarcinoma |
Malignant |
|
C6 |
22 |
F |
55 |
Ovary |
Adenocarcinoma |
Malignant |
|
C7 |
23 |
M |
45 |
Soft tissue |
Giant cell tumor of thigh |
Malignant |
|
C8 |
24 |
M |
45 |
Soft tissue |
Giant cell tumor of thigh |
Malignant |
|
D1 |
25 |
M |
62 |
Skin |
Squamous cell carcinoma |
Malignant |
|
D2 |
26 |
M |
62 |
Skin |
Squamous cell carcinoma |
Malignant |
|
D3 |
27 |
M |
78 |
Skin |
Squamous cell carcinoma |
Malignant |
|
D4 |
28 |
M |
78 |
Skin |
Squamous cell carcinoma |
Malignant |
|
D5 |
29 |
M |
46 |
Oral cavity |
Mullerian mixed tumor |
Malignant |
|
D6 |
30 |
M |
46 |
Oral cavity |
Mullerian mixed tumor |
Malignant |
|
D7 |
31 |
M |
46 |
Oral cavity |
Mullerian mixed tumor |
Malignant |
|
D8 |
32 |
M |
46 |
Oral cavity |
Mullerian mixed tumor |
Malignant |
|
E1 |
33 |
M |
47 |
Lung |
Squamous cell carcinoma |
Malignant |
|
E2 |
34 |
M |
47 |
Lung |
Squamous cell carcinoma |
Malignant |
|
E3 |
35 |
M |
54 |
Lung |
Bronchioalveolar carcinoma |
Malignant |
|
E4 |
36 |
M |
54 |
Lung |
Bronchioalveolar carcinoma |
Malignant |
|
E5 |
37 |
F |
48 |
Ovary |
Adenocarcinoma |
Malignant |
|
E6 |
38 |
F |
48 |
Ovary |
Adenocarcinoma |
Malignant |
|
E7 |
39 |
M |
37 |
Testis |
Seminoma |
Malignant |
|
E8 |
40 |
M |
37 |
Testis |
Seminoma |
Malignant |
† For precise diagnosis, refer to pathology description.
|
|
